Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rats Plague Arena's Diet Pill
Minyanville
Saturday, January 29, 2011 - 11:20am
tags:
Arena Pharmaceuticals, Orexigen, obesity, diet drugs, Qnexa, Vivus
Harwood Feffer LLP Announces It Has Amended Its Class Action Complaint Against Genzyme Corporation
Yahoo/Globe NewsWire
Saturday, January 29, 2011 - 11:17am
tags:
Genzyme, lawsuits
Downtrend Spotted in Shares of KV Pharmaceutical (KV.A)
Benzinga
Saturday, January 29, 2011 - 11:15am
tags:
KV Pharmaceutical, investors
Digging For Data: M&A For Pharma IT Rises
Pharmalot
Friday, January 28, 2011 - 12:15pm
tags:
M&A
How GlaxoSmithKline Lost $635M in Bad Bets on Sleeping Pills
BNET Pharma
Friday, January 28, 2011 - 12:14pm
tags:
GSK, insomnia, Actelion, almorexant, Lunesta, Sunovion
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Friday, January 28, 2011 - 12:13pm
tags:
Orexigen, Contrave, Arena Pharmaceuticals, Vivus, Avanir, Discovery Labs, Cel-Sci
Earnings Preview: Pfizer report to focus on deals
Yahoo/AP
Friday, January 28, 2011 - 12:10pm
tags:
earnings, Pfizer, Medicines Company, Bristol-Myers Squibb
Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Bloomberg
Friday, January 28, 2011 - 12:09pm
tags:
Myriad Genetics, Sanofi, BSI-201, breast cancer
The Feds Are Investigating How Many Fraud Cases?
Pharmalot
Friday, January 28, 2011 - 9:44am
tags:
fraud, whistleblowers, HHS
Roche’s Tarceva Extends Lives, Study Stopped Early
Bloomberg
Friday, January 28, 2011 - 9:41am
tags:
Astellas, Tarceva, lung cancer, Roche
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Yahoo
Friday, January 28, 2011 - 9:40am
tags:
Endo, Orion, R&D, cancer
CyDex Pharmaceuticals sells to Ligand Pharmaceuticals
Bizjournals.com
Friday, January 28, 2011 - 9:39am
tags:
CyDex Pharmaceuticals, Ligand, M&A
Sales Potential and Chances of FDA Approval for DepoMed's DM-1796
Seeking Alpha
Friday, January 28, 2011 - 9:37am
tags:
FDA, DM-1796, Depomed, gabapentin, Pfizer, Abbott Laboratories, XenoPort
Arena Fires 25% of Workforce After Diet Drug Delay
Bloomberg
Thursday, January 27, 2011 - 9:39pm
tags:
Arena Pharmaceuticals, layoffs
Trading Orexigen's PDUFA Event
Seeking Alpha
Thursday, January 27, 2011 - 9:38pm
tags:
Orexigen, PDUFA, Contrave
Pain Therapeutics gets June 23 FDA date for Remoxy
Yahoo/AP
Thursday, January 27, 2011 - 9:37pm
tags:
Pain Therapeutics, Remoxy, FDA, Pfizer, Durect Corporation
Sanofi’s Breast Cancer Drug Fails in Advanced Trial
Bloomberg
Thursday, January 27, 2011 - 7:18pm
tags:
breast cancer, Sanofi, BSI-201
Abbott Labs: Growth in All the Wrong Places
Motley Fool
Thursday, January 27, 2011 - 7:17pm
tags:
Abbott Laboratories, earnings
Mead Johnson 4Q profit jumps 56 percent
Yahoo/AP
Thursday, January 27, 2011 - 7:16pm
tags:
earnings, Mead Johnson
Abbott Blames Obamacare for 1,900 Layoffs, but Financials Tell a Different Story
BNET Pharma
Thursday, January 27, 2011 - 11:38am
tags:
Abbott Laboratories, layoffs, earnings, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.